Literature DB >> 25902308

The Development of a Validated Checklist for Ultrasound-Guided Thyroid Nodule Fine-Needle Aspiration Biopsies: Preliminary Results.

Ezekiel Maloney1, Philip Dougherty, Manjiri Dighe, Annemarie Relyea-Chew.   

Abstract

Ultrasound-guided fine-needle aspiration (USgFNA) is the procedure of choice for biopsy of thyroid nodules (TNs) that are suspicious for malignancy. Poor technique in performing this procedure can result in nondiagnostic specimens, increased patient anxiety, repeated aspirations, and unnecessary surgery. Validated checklists are a central component of teaching and assessing procedural skills. The results of the first step of the validation of a TN USgFNA checklist are described. A comprehensive review of articles published on TN fine-needle aspiration did not yield a validated checklist. A modified Delphi technique, involving a panel of 8 interdisciplinary experts, was used to develop a TN USgFNA checklist. The internal consistency coefficient using Cronbach α was 0.74. Development of the 23-item TN USgFNA checklist for teaching and assessing TN USgFNA is the first step in the validation process. Further validation can be achieved via implementation and study of the checklist in clinical settings.

Entities:  

Mesh:

Year:  2015        PMID: 25902308     DOI: 10.1097/RUQ.0000000000000137

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  2 in total

1.  Novel cricothyrotomy assessment tool for attending physicians: A multicenter study of an error avoidance checklist.

Authors:  Sara M Hock; Jerome J Martin; Stephen C Stanfield; Thomas R Alcorn; Emily S Binstadt
Journal:  AEM Educ Train       Date:  2021-08-01

2.  Clinical and histopathological characteristics of patients with incidental and nonincidental thyroid cancer.

Authors:  Krzysztof Kaliszewski; Dorota Diakowska; Marta Strutyńska-Karpińska; Beata Wojtczak; Paweł Domosławski; Waldemar Balcerzak
Journal:  Arch Med Sci       Date:  2016-04-27       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.